BD-2, human recombinant protein
Skin-antimicrobial peptide 1, SAP1
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | O15263 |
---|---|
Calculated MW | 4.3 kDa |
Gene ID | 1673 |
---|---|
Gene Symbol | DEFB2 |
Other Names | Skin-antimicrobial peptide 1, SAP1, Beta-defensin 2, Defensin, beta 2, Skin-antimicrobial peptide 1, DEFB4A, DEFB102, DEFB2, DEFB4, DEFB4B |
Gene Source | Human |
Source | E. coli |
Assay&Purity | SDS-PAGE; ≥98% |
Assay2&Purity2 | HPLC; ≥98% |
Recombinant | Yes |
Results | 10-100 ng/ml |
Target/Specificity | BD-2 |
Application Notes | Reconstitute in ddH₂O to a concentration of 0.1-1.0 mg/ml. The solution can then be diluted into other aqueous buffers or store d at 4°C for 1 week or –20°C for future use. |
Format | Lyophilized protein |
Storage | -20°C; Sterile filtered and lyophilized with no additives |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Recombinant human β-defensin-2 (BD-2) is an antimicrobial peptide which belongs to the distinct family of β-defensins. Recombinant human BD-2 is a 4.3 kDa protein containing 41 amino acid residues.
References
Harder J.,et al.Nature 387:861-861(1997).
Liu L.,et al.Gene 222:237-244(1998).
Diamond G.,et al.Infect. Immun. 68:113-119(2000).
Harder J.,et al.Am. J. Respir. Cell Mol. Biol. 22:714-721(2000).
Kluever E.,et al.J. Pept. Res. 59:241-248(2002).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.